FeaturedNeurology·March 29, 2017·7 min readNew Multiple Sclerosis Drug, Backed by 40 Years of Research, Could Halt DiseaseFDA approves a new drug to treat both relapsing-remitting multiple sclerosis and primary progressive MS.Read More
FeaturedNeurologyNeuroscience·January 15, 2022·4 min readHydroxychloroquine Delays Disability for Least Treatable Form of Multiple SclerosisHydroxychloroquine shows promise for reducing some of the debilitating systems associated with primary progressive multiple sclerosis, a new study reports.Read More
FeaturedGeneticsNeurology·September 18, 2017·5 min readMarkers For Severe Form of Multiple Sclerosis IdentifiedResearchers from Yale University have discovered tow cytokines that could help explain how some people develop PPMS. They report a simple genetic test could be used to identify those most at risk of developing progressive multiple sclerosis.Read More
FeaturedNeurologyOpen Neuroscience Articles·January 9, 2017·5 min readBreakthrough in Multiple Sclerosis TreatmentClinical trials show that a new drug called ocrelizumab can reduce attacks in people with RRMS, and can reduce new symptom development in patients with primary progressive multiple sclerosis.Read More
FeaturedNeurology·April 21, 2017·3 min readPreliminary Study Suggests Possible New Treatment for MSAccording to researchers, a small preliminary study could show promise for a new treatment for those with primary progressive multiple sclerosis.Read More
FeaturedNeurology·December 22, 2016·4 min readNew Treatment Strategy Has Unprecedented Effects in Relapsing Form of Multiple SclerosisClinical trials are showing positive results for the treatment of both relapsing multiple sclerosis and primary progressive MS.Read More
